| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930502 | Cytotherapy | 2015 | 10 Pages |
Abstract
Intravenous delivery of a single high-dose infusion of oMPCs is well tolerated in a large animal model. This study provides additional safety evidence for their intravenous use in future human clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Courtney A. McDonald, David Oehme, Yen Pham, Kilian Kelly, Silviu Itescu, Anne Gibbon, Graham Jenkin,